Treatment of sigmoid sinus thrombosis with long-term anticoagulation therapy remains controversial. We present the case of a 6-year-old boy with intraoperatively confi rmed sigmoid sinus thrombosis secondary to acute otomastoiditis. Combined-modality treatment-including mastoidectomy, sigmoid sinus decompression, and antibiotic and anticoagulation therapy-resulted in a complete clinical resolution of the patient's signs and symptoms. However, a 19-month follow-up with magnetic resonance venography demonstrated that the sigmoid sinus thrombosis itself had not resolved. It is clear that occlusion of the sigmoid sinus may persist aft er the completion of surgical and medical therapy for sigmoid sinus thrombosis secondary to otomastoiditis. It remains unclear (1) whether anticoagulation treatment aids in recanalization of the aff ected sinus and (2) whether patient outcomes are aff ected if recanalization is achieved.
Introduction
Th rombosis of the sigmoid sinus has long been recognized as an important complication of infections of the middle ear and mastoid cavity. Treatment involves surgical exploration of the mastoid cavity, venous sinus decompression, and long-term antibiotic therapy. Th e role of anticoagulation and its eff ect on the long-term evolution of sinus thrombosis remain controversial.
We present a case of sigmoid sinus thrombosis secondary to otitis media and mastoiditis that was followed over the course of 19 months by magnetic resonance venography (MRV). Th e length of follow-up in this case provides a unique opportunity to study the natural history of sigmoid sinus thrombosis treated with anticoagulation and to determine if there is any correlation between this treatment and clinical outcome. A 6- year-old boy presented with a 3-day history of vomiting, headaches, dizziness, and lethargy aft er 2 days of treatment for acute otitis media with oral amoxicillin. Th e patient had no other signifi cant medical history. Physical examination revealed infl ammation of the right tympanic membrane and external auditory canal. Th e left tympanic membrane was opaque. Th ere were no focal neurologic fi ndings. Findings on routine laboratory tests were all within normal limits, including a normal white blood cell count. Computed tomography (CT) of the head and neck with contrast revealed a space-fi lling defect that was suspicious for right-sided sigmoid sinus thrombosis. Th e patient was admitted to the pediatric intensive care unit and started on subcutaneous enoxaparin (a lowmolecular-weight heparin [LMWH]) and intravenous ceft riaxone, vancomycin, and metronidazole.
Case report
During hospitalization, further radiographic evaluation of the cranial venous sinuses by MRV confi rmed the diagnosis of sigmoid sinus thrombosis (fi gure, A). CT of the temporal bones with contrast was signifi cant for bilateral mastoiditis, with coalescence on the right.
Th e patient underwent a right mastoidectomy, right
The healthcare environment is always changing, and as a medical professional, you want to protect your investment by purchasing equipment that will last. randomized, double-blind, placebo-controlled trial of LMWH by de Bruijn and Stam failed to fi nd any statistically signifi cant diff erence in outcomes favoring the active-treatment group. 2 A few case series have been reported in which anticoagulation was used for the treatment of sigmoid sinus thrombosis as a complication of otomastoiditis, but none included any data on long-term sinus recanalization. [3] [4] [5] [6] In 2008, Zhang et al reported their experience with treating 6 patients for cerebral sinus thrombosis with rheolytic thrombectomy coupled with thrombolytic therapy with sigmoid sinus decompression, and bilateral myringotomy with tympanostomy tube placement. Exploration revealed signifi cant sclerosis of the right mastoid cavity and the presence of mounds of granulation tissue. Th ere was no natural dehiscence of the sigmoid sinus, which was subsequently decompressed with a window measuring 2.5 cm × 8 mm. Th e surface of the sinus was signifi cantly hyperemic. Th e sinus was not aspirated. No intraoperative complications were noted, and the patient was returned to the pediatric intensive care unit on enoxaparin, ceft riaxone, vancomycin, and metronidazole.
Culture of fl uid obtained from the left ear and the contents of the right mastoid cavity were negative for growth. Pathologic evaluation of samples taken from the right mastoid cavity revealed fi brosis and chronic infl ammatory changes. Th e remainder of the patient's hospital course was unremarkable, and he was discharged home on postoperative day 9 on oral cefprozil and subcutaneous enoxaparin. Th e cefprozil was continued for 6 weeks postoperatively, and the subcutaneous enoxaparin was continued for 7 months.
Th roughout outpatient follow-up, the patient was well, and he exhibited no signs or symptoms of otomastoiditis or sigmoid sinus thrombosis. However, at 3 months postoperatively and again at 19 months, MRV showed no recanalization of the sigmoid sinus (fi gure, B).
Discussion
Th e long-term evolution of sigmoid sinus thrombosis, its correlation with a patient's clinical condition, and the need for long-term anticoagulation therapy remain controversial. Our patient was treated with a LMWH for 7 months postoperatively. Although his signs and symptoms resolved completely, follow-up MRV at 3 months and 19 months postoperatively failed to reveal any recanalization of the thrombosed sinus. MRV is an ideal modality for following the evolution of sigmoid sinus thrombosis; it is noninvasive, it requires no contrast, and it does not expose patients to any ionizing radiation.
Th e utility of anticoagulation therapy in patients with all types of cerebral sinus thrombosis has been studied, and results have been equivocal. Th e fi rst randomized, placebo-controlled study of the effi cacy of intravenous heparin in the treatment of cerebral venous sinus thrombosis was published in 1991 by Einhäupl et al, who found a statistically signifi cant diff erence in outcomes in favor of anticoagulation therapy. 1 However, that study involved only 20 patients. A larger (N = 60) 
Figure. A: At presentation, MRV shows no venous fl ow in the right transverse and sigmoid sinuses. B: At 19 months postoperatively, MRV indicates no signifi cant recanalization, as no venous fl ow is again observed in the right transverse and sigmoid sinuses.
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Improving Patient Care locally administered low-dose recombinant tissue plasminogen activator (rt-PA). 5 All patients in their study had multiply thrombosed sinuses and deteriorating clinical conditions, including vision loss, seizures, and coma. None of the patients had an otogenic etiology for their thrombosed sinuses. Although the short-term eff ects of rt-PA therapy might have been benefi cial, the long-term outcomes did not appear to correlate with long-term recanalization of the thrombosed sinuses. One patient who experienced a complete rethrombosis of the aff ected sinuses had an excellent clinical outcome with no residual defi cits, while a patient with complete patency developed visual-spatial and neurocognitive defi cits that required ongoing rehabilitation and precluded her from working and driving during a 10-month follow-up.
Bradley et al reported 9 cases of otogenic sigmoid sinus thrombosis, 6 of which were treated with anticoagulation. 6 Th ey asserted that treatment recommendations based on the neurology, hematology, and neurosurgery literature-which deal with cerebral sinus thrombosis in a variety of locations with both septic and aseptic etiologies and more severe outcomes-were not necessarily applicable to patients with otogenic sigmoid sinus thrombosis.
In 1985, Bousser et al published a series of 38 patients with all types of cerebral venous sinus thrombosis. 7 Twenty-three of these patients were treated with heparin, while 15 were not. Th ere were no deaths in the anticoagulated group, but 4 deaths in the nonanticoagulated group.
In 1995, Garcia et al reviewed the existing literature and found 58 reported cases of solely otogenic sigmoid sinus thrombosis. 8 All of these patients received antibiotics and 53 underwent some form of surgical intervention, but only 2 received heparin. Of these 2 anticoagulated patients, only 1 had evidence of a partial recanalization, which was seen on magnetic resonance imaging approximately 2 weeks aft er starting therapy.
Our patient underwent surgical therapy plus 6 weeks of antibiotics and 7 months of LMWH. Yet despite these therapies, and despite the patient's complete clinical recovery, long-term follow-up with MRV did not reveal any recanalization of the thrombosed sigmoid sinus.
In conclusion, the use of anticoagulants in the treatment of sigmoid sinus thrombosis and their relationship to the natural history of sigmoid sinus thrombosis and patient outcomes remain unclear. Current trends in the literature suggest that anticoagulation, complete clinical recovery, and recanalization of a thrombosed sinus are unrelated. Our experience supports this view.
